3-iodobenzylguanidine has been researched along with 22q11.2 Deletion Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Booij, J; Boot, E; Somsen, GA; van Amelsvoort, TA; van Eck-Smit, BL; Verberne, HJ; Verschure, DO | 1 |
1 other study(ies) available for 3-iodobenzylguanidine and 22q11.2 Deletion Syndrome
| Article | Year |
|---|---|
Cardiac sympathetic activity in 22q11.2 deletion syndrome.
Topics: 3-Iodobenzylguanidine; Adult; alpha-Methyltyrosine; DiGeorge Syndrome; Female; Heart; Humans; Image Interpretation, Computer-Assisted; Male; Myocardial Perfusion Imaging; Radiopharmaceuticals; Young Adult | 2016 |